The assessment available on Elysium Pathways website does not create a doctor-patient relationship. Clinical services are provided by OpenLoop Health and other networks of U.S.-licensed clinicians who determine eligibility for GLP-1 treatment based on medical history and assessment responses. Providers retain full discretion to prescribe or decline compounded GLP-1 medications. Compounded medications offered through Elysium Pathways are produced in FDA-registered facilities but are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality. Results may vary and depend on individual adherence, provider guidance, and lifestyle changes. Elysium Pathways does not manufacture compounded medications, and product appearance may differ from website images. Elysium Pathways partners with certified U.S. pharmacies to ensure high standards of safety and quality. Medication costs are included in the Elysium Pathways program. Zepbound® is FDA-approved for chronic weight management; Ozempic® is FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight management. All trademarks are the property of their respective owners. Unless otherwise noted, results reflect Elysium Pathways patient experiences rather than public clinical studies.
Copyright 2026 Elysium Pathways. All rights reserved.
